LSM2 Human

LSM2 Homolog, U6 Small Nuclear RNA Associated Human Recombinant
Shipped with Ice Packs
In Stock

Description

LSM2 participates in distinct cellular processes depending on its complex composition:

  • Lsm2–8 Complex (Nuclear): Stabilizes U6 small nuclear RNA (snRNA) by recognizing its terminal 2′,3′ cyclic phosphate group. This interaction induces a sharp RNA bend, positioning the terminal uracil in a rare syn conformation for precise binding .

  • Lsm1–7 Complex (Cytoplasmic): Directs mRNA decay by binding oligouridylate tracts, particularly those ending in purines .

Key Functional Differences

ComplexRNA TargetBinding Specificity
Lsm2–8U6 snRNA2′,3′ cyclic phosphate recognition
Lsm1–7mRNA (oligouridylate)Purine-rich 3′ ends, lacks cyclic phosphate affinity

Interactions and Partners

LSM2 interacts with multiple proteins and RNAs:

  • Protein Partners: DDX20, LSM3, LSM7, LSM8 .

  • RNA Targets: U6 snRNA (via Lsm2–8), mRNA (via Lsm1–7) .

Expression Patterns

TissueLSM2 ExpressionFunctional Context
BrainHighRNA splicing and U6 snRNA stabilization
TestisHighGerm cell development and mRNA regulation
LiverModerateMetabolic RNA processing

Research Findings and Mechanisms

  • Structural Basis of RNA Recognition: X-ray crystallography revealed Lsm2–8 binds U6 snRNA via a cyclic phosphate-induced RNA bend, enabling specific syn-uracil interactions .

  • Therapeutic Potential: LSM2 silencing in SKCM models reduces tumor progression, suggesting it as a candidate for targeted therapies .

  • Functional Associations: LSM2 is linked to molecular processes (e.g., RNA decay, splicing) and diseases (e.g., cancer, neurodegeneration) across 5,021 functional associations .

Product Specs

Introduction
LSM2, a member of the snRNP Sm protein family, belongs to a group of proteins identified in various organisms based on their sequence homology to the Sm protein family. Characterized by the Sm sequence motif, these proteins feature two regions separated by a variable-length linker that folds into a loop. Sm-like proteins are thought to form a stable heteromer found in tri-snRNP particles, which are crucial for pre-mRNA splicing. LSM2 specifically binds to the 3'-terminal U-tract of U6 snRNA, playing a vital role in pre-mRNA splicing.
Description
Recombinant human LSM2, produced in E. coli, is a single polypeptide chain comprising 119 amino acids (1-95) with a molecular weight of 13.4 kDa. The protein is fused to a 24-amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless, and sterile-filtered solution.
Formulation
The LSM2 solution is provided at a concentration of 0.5 mg/mL in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 200 mM NaCl, 5 mM DTT, and 40% glycerol.
Stability
For short-term storage (up to 2-4 weeks), the solution can be stored at 4°C. For extended storage, freeze the solution at -20°C. Adding a carrier protein like HSA or BSA (0.1%) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
The purity of LSM2 is greater than 90% as determined by SDS-PAGE analysis.
Synonyms
LSM2 homolog U6 small nuclear RNA associated (S. cerevisiae), Small nuclear ribonuclear protein D homolog, chromosome 6 open reading frame 28, snRNP core Sm-like protein Sm-x5, C6orf28, YBL026W, Protein G7b, snRNP.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMLFYSF FKSLVGKDVV VELKNDLSIC GTLHSVDQYL NIKLTDISVT DPEKYPHMLS VKNCFIRGSV VRYVQLPADE VDTQLLQDAA RKEALQQKQ

Q&A

How can researchers effectively control for confounding variables when analyzing LSM2 function in cellular models?

Controlling confounding variables is critical when analyzing LSM2 function in cellular models. First, conduct careful keyword research to identify all known factors that influence LSM2 activity based on previous literature . Standardize cell culture conditions including passage number, confluence level, and culture media composition across all experimental groups . When designing treatments to manipulate your independent variable (such as LSM2 knockdown or overexpression), include appropriate controls: empty vector controls for overexpression studies, non-targeting siRNA/shRNA controls for knockdown experiments, and mock-transfected controls . For valid comparisons, employ random assignment of cultures to treatment conditions and blind the researcher conducting the analyses to experimental conditions . Additionally, measure potential confounding molecular factors (cell cycle status, stress response activation) alongside your dependent variables to allow statistical control through covariate analysis if necessary.

What methods provide the most reliable quantification of LSM2 protein levels in human samples?

For reliable quantification of LSM2 protein levels, combine complementary methodological approaches. Western blotting with chemiluminescent detection offers good sensitivity when optimized with validated anti-LSM2 antibodies, appropriate loading controls (such as β-actin or GAPDH), and standard curves using recombinant LSM2 protein . ELISA provides more precise quantification and higher throughput but requires careful validation against known LSM2 concentrations. For spatial distribution analysis, immunohistochemistry or immunofluorescence with appropriate negative and positive controls allows visualization of LSM2 localization within tissues or cells . Mass spectrometry-based proteomics offers the most comprehensive analysis, allowing absolute quantification of LSM2 alongside detection of post-translational modifications and binding partners. Always perform technical triplicates and include inter-assay calibrators when quantifying across multiple experimental runs. Document all methodological details following MIQE (Minimum Information for Publication of Quantitative Real-Time PCR Experiments) or equivalent guidelines appropriate to your quantification method.

How can researchers design experiments to investigate LSM2's role in complex RNA processing pathways?

To investigate LSM2's role in complex RNA processing pathways, implement a multi-level experimental design that examines both physical interactions and functional consequences . Begin by establishing clear hypotheses about specific RNA species or processing steps potentially affected by LSM2. For protein-RNA interaction studies, combine CLIP-seq (Cross-linking immunoprecipitation sequencing) with RNA immunoprecipitation followed by high-throughput sequencing to identify RNA binding partners of LSM2 . Complement these approaches with proximity ligation assays to visualize interactions in situ. For functional analysis, design experiments that manipulate LSM2 levels (through CRISPR-Cas9 editing, inducible knockdown, or overexpression systems) and measure effects on RNA processing using RNA-seq with specialized library preparation protocols that capture different RNA species (e.g., nascent RNA, mature mRNA, small RNAs) . Include time-course experiments to differentiate direct from secondary effects. Employ careful statistical analysis for high-dimensional data, using false discovery rate correction for multiple testing and independent validation of key findings in different cell types or tissue samples.

What are the methodological challenges in resolving contradictory findings about LSM2 function across different experimental systems?

Resolving contradictory findings about LSM2 function requires systematic analysis of methodological variables across studies . Create a structured comparison table documenting key methodological differences including: experimental model systems (cell lines, primary cells, tissues, organisms), genetic background, LSM2 detection methods (antibodies used, validation methods), manipulation approaches (knockdown efficiency, overexpression levels), and endpoint measurements . Consider whether contradictions arise from cell type-specific functions, post-translational modifications, or context-dependent interactions. Design experiments that directly test competing hypotheses in parallel using identical methods across different models. When conducting your own research to resolve contradictions, include multiple orthogonal techniques to measure the same biological outcome and deliberately vary one methodological parameter at a time . Collaborate with laboratories reporting contradictory results to standardize protocols and exchange materials. Use meta-analytical approaches to systematically evaluate the strength of evidence for different models of LSM2 function, accounting for publication bias and methodological quality.

How should researchers integrate multi-omics data to comprehensively understand LSM2's functional networks?

Integrating multi-omics data for LSM2 research requires a systematic analytical framework. Begin with parallel omics experiments (transcriptomics, proteomics, interactomics) using the same biological samples or closely matched conditions to ensure comparability . Implement a tiered analytical approach: first analyze each dataset independently using platform-appropriate statistical methods, then perform integrative analyses that connect findings across platforms. For network analysis, construct protein-protein interaction networks centered on LSM2 using experimental data (co-immunoprecipitation, proximity labeling) supplemented with database information, then overlay transcriptomic responses to LSM2 perturbation . Apply pathway enrichment analysis across integrated datasets to identify biological processes consistently affected across different data types. Validate key network connections using targeted experimental approaches such as co-immunoprecipitation, genetic interaction studies (synthetic lethality/sickness screens), or visualization of co-localization . Document computational methods thoroughly, including software versions, parameters, and statistical thresholds, and make raw data available through appropriate repositories to enable reproducibility. Consider temporal dynamics by collecting time-series data that can reveal causal relationships within the network.

What controls are essential when designing LSM2 knockdown or knockout experiments in human cell models?

When designing LSM2 knockdown or knockout experiments, implementation of rigorous controls is essential for valid interpretation . For siRNA/shRNA-mediated knockdown, include multiple non-targeting control sequences that activate the RNAi machinery without targeting any human transcripts. Use at least two independent targeting sequences for LSM2 to control for off-target effects, and validate knockdown efficiency at both mRNA (qRT-PCR) and protein levels (Western blot) . For CRISPR-Cas9 knockout experiments, include both non-targeting gRNA controls and controls targeting non-essential genes with similar expression levels to LSM2. Generate and characterize multiple independent knockout clones, as clonal variation can confound results . Consider implementing rescue experiments by expressing RNAi-resistant or gRNA-resistant LSM2 variants to confirm phenotype specificity. For all genetic manipulation experiments, conduct comprehensive off-target analysis through RNA-seq to identify transcriptome-wide effects. Time-course experiments are critical, as acute versus chronic LSM2 depletion may yield different phenotypes due to compensatory mechanisms. Finally, include wild-type parental cells subjected to the same selection procedures as an additional control to account for effects of the selection process itself.

How can researchers effectively design experiments to study LSM2's role in dynamic RNA processing events?

Studying LSM2's role in dynamic RNA processing requires experimental designs that capture temporal changes with sufficient resolution . Implement pulse-chase experiments using metabolic labeling of newly synthesized RNA (e.g., 4sU incorporation) followed by purification and sequencing to track RNA processing kinetics in the presence or absence of LSM2. Use inducible systems (tetracycline-regulated expression, auxin-inducible degradation) to achieve temporal control of LSM2 levels, allowing observation of immediate versus delayed effects on RNA processing . For visualization of dynamic processes, employ MS2-tagged RNA combined with fluorescently labeled MS2 coat protein to track RNA localization and processing in living cells. Design experiments with multiple time points rather than endpoint analyses, using statistical methods appropriate for time-series data (repeated measures ANOVA, mixed-effects models) . When studying co-transcriptional RNA processing, combine chromatin immunoprecipitation with nascent RNA analysis to correlate LSM2 occupancy with processing events. Control for cell cycle effects by synchronizing cells or using single-cell approaches to deconvolute cell cycle stage from your measurements. Document all time intervals precisely and ensure consistent timing across experimental replicates to minimize technical variability.

Product Science Overview

Gene and Protein Structure

The LSM2 gene is located on chromosome 6 in humans and is also known by several aliases, including C6orf28, G7B, and YBL026W . The protein encoded by LSM2 contains the Sm sequence motif, which consists of two regions separated by a linker of variable length that folds as a loop . This structure is crucial for its function in RNA binding and processing.

Function and Mechanism

LSM2 is a component of the U4/U6-U5 tri-snRNP complex, which is involved in spliceosome assembly . The spliceosome is a complex molecular machine responsible for removing introns from pre-mRNA, a critical step in mRNA maturation. LSM2, along with other LSm proteins, forms a stable heteromer that binds specifically to the 3’-terminal oligo(U) tract of U6 snRNA . This binding is essential for the formation of the U4/U6 duplex, which is a prerequisite for the assembly of the spliceosome .

Additionally, LSM2 is involved in mRNA degradation pathways, including deadenylation-dependent mRNA decay . This process is vital for regulating mRNA stability and, consequently, gene expression.

Biological Significance

The proper functioning of LSM2 is crucial for cellular RNA metabolism. Dysregulation of LSM2 and its associated pathways can lead to various diseases. For instance, LSM2 has been implicated in mixed connective tissue disease and cat-scratch disease . Moreover, its role in RNA splicing and degradation makes it a potential target for therapeutic interventions in diseases where RNA processing is disrupted.

Research and Applications

Human recombinant LSM2 is used in various research applications to study its function and interactions. By expressing and purifying recombinant LSM2, researchers can investigate its role in RNA metabolism and its potential as a therapeutic target. Studies have shown that LSM2 interacts with other proteins such as DDX20, LSM3, LSM7, and LSM8, highlighting its involvement in complex RNA processing networks .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.